Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday ended up being a positive day for the broad U.S. markets. The major indices started the day out incredibly negative and over the course of the day worked their way up to a…
Wednesday ended up being a positive day for the broad U.S. markets. The major indices started the day out incredibly negative and over the course of the day worked their way up to a…
Fortnite is taking the world by storm. And this could spell some problems for major video game publishers.
Tesla said in its first-quarter update that it "does not require an equity or debt raise this year," although this has analysts somewhat skeptical.
After Dave & Buster’s released its most recent quarterly results, the stock hit a new 52-week low.
When Cloudera reported its fiscal fourth-quarter financial results, it looked like a strong quarter with solid beats on both the top and bottom lines.
Proteostasis Therapeutics shares made a solid gain on Wednesday after a key FDA decision was announced.
CarMax released disappointing fourth-quarter financial results before the markets opened on Wednesday.
Tuesday was a positive day for the broad U.S. markets, a slight recovery from Monday’s dramatic session. Everything seemed to perk up a little, even oil made a small recovery as well. And even…
Spotify stock has absolutely exploded in the market, confirming practically all the bullish analysts ahead of the offering.
YogaWorks released its most recent quarterly results after the markets closed on Monday and shares tumbled on Tuesday.
The Brewers Association (BA), a not-for-profit trade group representing small independent craft brewers, released a study showing how American craft beer is rising to prominence on the international scene.
Jamie Dimon and others have called bitcoin and cryptocurrencies in general fraudulent. And now it seems the SEC is proving them right.
Celgene is shuffling the deck in terms of its executive leadership, and one of its top executives is stepping down.
Rigel Pharmaceuticals saw its shares pull back early on Tuesday after the firm announced topline data from a midstage study.
Monday was a down day for the broad U.S. markets, with each index posting a loss of at least 1.9%. With Monday’s lower close that marks the eleventh time out of the past 15…
Pfizer shares took a small step back on Monday despite announcing positive results from a late-stage trial. The pullback seems to be the product of overall market sentiment as opposed to these results.
GrubHub shares pulled back slightly to kick off the week after the company announced that it would be expanding its business.
SORL Auto Parts reported mixed fourth-quarter financial results before the markets opened on Monday.
Alkermes saw its shares drop early on Monday after the company announced that it received a Refusal to File letter from the FDA.
Here is a 24/7 Wall St. calendar with a few of the biggest biotech and pharmaceutical companies expecting clinical trial and FDA updates in April.